Journal
Blood Advances
Publication Date
6-25-2024
Volume
8
Issue
12
First Page
3189
Last Page
3199
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2023011657
Rights and Permissions
Batchelor TT, Giri S, Ruppert AS, Geyer SM, Smith SE, Mohile N, Swinnen LJ, Friedberg JW, Kahl BS, Bartlett NL, Hsi ED, Cheson BD, Wagner-Johnston N, Nayak L, Leonard JP, Rubenstein JL. Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood Adv. 2024 Jun 25;8(12):3189-3199. doi: 10.1182/bloodadvances.2023011657. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Batchelor, Tracy T; Kahl, Brad S; Bartlett, Nancy L; Wagner-Johnston, Nina; and et al., "Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: Results of Alliance 51101." Blood Advances. 8, 12. 3189 - 3199. (2024).
https://digitalcommons.wustl.edu/oa_4/4111
Additional Links
Supplemental material is available for this article at publisher site.
